Results 191 to 200 of about 106,856 (342)

Dissemination planning in exercise oncology trials-a systematic review of trial protocols. [PDF]

open access: yesSupport Care Cancer
Smyth E   +4 more
europepmc   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross‐Reactivity and Reintroduction in Chinese Population

open access: yesAllergy, EarlyView.
Clinical history including self‐reported history and oral food challenge outcome, and sIgE sensitization profile of 200 subjects with suspected fish allergy was analyzed to construct a 3‐step fish allergenicity ladder. The allergenicity ladder was positively linked to the relative parvalbumin content of fish muscle but not to differences in the IgE ...
Christine Y. Y. Wai   +21 more
wiley   +1 more source

Gene–Environment Interaction Affects Risk of Atopic Eczema: Population and In Vitro Studies

open access: yesAllergy, EarlyView.
Atopic eczema is a complex trait resulting from multiple genetic and environmental factors. This study investigated evidence for interaction between 24 established eczema genetic risk variants and 18 environmental factors. One variant‐environmental pair showed nominally significant interaction in discovery, replication and meta‐analyses: early‐life dog
Marie Standl   +77 more
wiley   +1 more source

Home - About - Disclaimer - Privacy